News
Another Opdivo failure for BMS, "highly disturbing" stats on childhood diabetes, and Trump left red-faced as his 'America first' manufacturing policy...
The prices of generic drugs have been driven lower as companies compete to undercut one another. This has led to dramatic changes in the fiercely...
Pfizer has received a bittersweet bout of news as it emerges that its drug Besponsa (inotuzumab ozogamicin) has received approval in the US, but...
It was a case of three-in-one bits of good news for AstraZeneca and MSD, after the FDA boosted the newly formed Lynparza partnership with an expanded...
Newcastle upon Tyne Hospital’s Chief Executive, Leonard Fenwick, has been sacked from his position after a disciplinary panel adjudged he had...
Two studies published in Nature may be able to explain some of the reasons for this and potentially offer a way to boost the success rates...
The FDA has announced that it has been forced to recall a range of liquid pharmaceutical and dietary supplement products due a possible bacterial...
Alexion announced that it had been granted three new patents for its lead product that will run through until 2027.
Novo Nordisk has revealed that its diabetes drug semaglutide managed to outperform Eli Lilly’s own treatment dulaglutide (Trulicity) in controlling...
Cancer Research UK and Newcastle University have announced that their existing research collaboration with Astex Pharmaceuticals will be extended for...
